Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry
Year: 2018
Type: article
Source: Pediatric Dermatology
DOI: 10.1111/pde.13452
Authors: Elaine C. Siegfried, Jennifer C. Jaworski, Lawrence F. Eichenfield, Amy Paller, Adelaide A. Hebert, Eric L. Simpson, Emily Altman, Charles Arena, Andrew Blauvelt, Julie Block, Mark Boguniewicz, Suephy Chen, Kelly Cordoro, Diane Hanna, Kimberly Horii, Thomas Hultsch, James Lee, Donald Y. Leung, Peter Lio, Joshua Milner, Theodore Omachi, Christine Schneider, Lynda Schneider, Robert Sidbury, Timothy Smith, Jeffrey Sugarman, Sharif Taha, Susan Tofte, Megha Tollefson, Wynnis L. Tom, Dennis P. West, Lucinda Whitney, Lee Zane
Institutions: Cardinal Glennon Children’s Medical Center, Saint Louis University, University of California San Diego, Rady Children's Hospital-San Diego, Northwestern University, Lurie Children's Hospital, The University of Texas Health Science Center at Houston, Oregon Health & Science University, Summit Medical Group (United States), Regeneron (United States), Oregon Medical Research Center, National Eczema Association, National Jewish Health, University of Colorado Anschutz, University of Colorado Denver, Emory University, Atlanta VA Medical Center, University of California, San Francisco, Children's Mercy Hospital, University of Missouri–Kansas City, National Institute of Allergy and Infectious Diseases, Genentech, Boston Children's Hospital, Harvard University, Seattle Children's Hospital, University of Washington, Mayo Clinic, University of Kansas Medical Center
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2795365540